首页 › 基金 › 683 Capital Management, LLC › TGTX
683 Capital Management, LLC 对 TGTX 的持仓历史
TG THERAPEUTICS · 医疗保健
683 Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 TGTX(TG THERAPEUTICS)389,081 股,市值约 US$21.4M,约占其申报组合的 1.14%,在其申报持仓中市值排名第 21 位。 683 Capital Management, LLC 最近 12 个申报季度中有 11 个季度披露了 TGTX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
683 Capital Management, LLC 对 TGTX 的持仓演变
683 Capital Management, LLC 于 Q3 2023 首次披露 TGTX 持仓:1,350,000 股(约 US$11.3M)。 该持仓在 Q3 2024 达到峰值 1,135,000 股,市值约 US$26.5M。 在 11 次申报中,683 Capital Management, LLC 3 次增持、6 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 389,081 股、市值约 US$21.4M,环比减持 -200,919 股。。 持仓曾出现大幅变动:Q4 2023 减持约 100% (随后一个季度股价下跌 11%)、Q1 2024 增持约 32400% (随后一个季度股价上涨 17%)、Q1 2026 增持约 64% (随后一个季度股价上涨 65%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.35M | $11.29M | 新进 |
| Q4 2023 | 5.00K | $85.40K | 减持 |
| Q1 2024 | 1.62M | $24.72M | 增持 |
| Q2 2024 | 1.40M | $24.91M | 减持 |
| Q3 2024 | 1.14M | $26.55M | 减持 |
| Q4 2024 | 697.00K | $20.98M | 减持 |
| Q1 2025 | 295.00K | $11.63M | 减持 |
| Q3 2025 | 325.00K | $11.74M | 新进 |
| Q4 2025 | 360.00K | $10.73M | 增持 |
| Q1 2026 | 590.00K | $19.60M | 增持 |
| Q2 2026 | 389.08K | $21.38M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TGTX 与 13F 数据
TGTX(TG THERAPEUTICS)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 TGTX,申报仓位最大的包括:Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Penn Capital Management Company, LLC (US$29.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TGTX 的基金
- Soleus Capital Management, L.P. 2.93M 股 · $160.86M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 2.61M 股 · $145.39M · Q3 2026
- Penn Capital Management Company, LLC 536.07K 股 · $29.51M · Q2 2026
- Opaleye Management Inc. 535.00K 股 · $29.39M · Q2 2026
- Occam Crest Management LP 425.00K 股 · $22.73M · Q2 2026
更多关于 683 Capital Management, LLC
常见问题
How long has 683 Capital Management, LLC held TGTX?
683 Capital Management, LLC has disclosed TGTX holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is 683 Capital Management, LLC's current position in TGTX?
As of Q2 2026, 683 Capital Management, LLC holds 389.08K shares of TGTX (TG THERAPEUTICS), valued at $21.38M, representing 1.14% of its reported portfolio and ranking #21.
Has 683 Capital Management, LLC been buying or selling TGTX?
In the latest 13F filing (Q2 2026), 683 Capital Management, LLC reduced its position in TGTX. The position peaked in Q3 2024 at 1.14M shares.
Which other funds hold TGTX?
Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Penn Capital Management Company, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.